retatrutide type 2 diabetes trial dosing The data just dropped — and is rewriting what's possible in obesity medicine. 🧬 TRIUMPH-1 just released Phase 3 results, and the numbers are unlike anything we've seen from a medication retatrutide clinical trial dosing trials

Some options include weight maintenance support groups, which can offer a safe space for encouragement, sharing experiences, and providing practical tips for sustaining weight loss

Petersen KF, Shulman GI

This is the same system that controls your fight or flight response and your blood vessel constriction

That includes reducing excess weight, of course

For tirzepatide (Zepbound) Jastreboff and colleagues reported in the New England Journal of Medicine in 2022 that at maximal doses, the percent of individuals reporting side effects were as follows: Nausea 31.0% Diarrhea 23.0% Vomiting 12.2% Constipation 11.7% Bettge and colleagues conducted a study published in Diabetes, Obesity, and Metabolism in 2017 that showed that individuals who were taking metformin while taking a GLP-1 were more likely to have side effects, especially nausea and vomiting

Therefore, investigating the unique impact of aging on different tissues can facilitate a precision medicine strategy for aging, allowing for personalized GLP-1 RA treatments aimed at addressing the main pathological mechanisms in each organ system